Latest advances in systemic therapies

Martin Sebastian (Frankfurt, Germany)

Source: ERS Online Course 2019: Essentials of modern lung cancer care – catch up with the latest advances

Number: 6

Disease area: -

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Martin Sebastian (Frankfurt, Germany). Latest advances in systemic therapies. ERS Online Course 2019: Essentials of modern lung cancer care – catch up with the latest advances

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Recent advances in data management Source: International Congress 2019 – New insights into quality control of lung function testing Year: 2019
New molecular-directed therapies for mesothelioma: have there been any advances? Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014
Recent advances from pathophysiology to medical therapy Source: Annual Congress 2010 - ERS Guidelines for the diagnosis and management of lymphangioleiomyomatosis Year: 2010
Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020
Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008
Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020
Some advances in COPD treatment and management Source: Eur Respir J 2004; 24: Suppl. 48, 85s Year: 2004
Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017
Advances in the therapeutical management of IPF Source: Annual Congress 2012 - MS3 Update in idiopatic pulmonary fibrosis Year: 2012
Current developments and future directions in respiratory physiotherapy Source: Eur Respir Rev, 29 (158) 200264; 10.1183/16000617.0264-2020 Year: 2020
Current developments and future directions in COPD Source: Eur Respir Rev, 29 (158) 200289; 10.1183/16000617.0289-2020 Year: 2020
Achievements in targeted therapies Source: Eur Respir Monogr 2015; 68: 215-233 Year: 2015
Clinical implications and novel therapies Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018